Combinations for the treatment of neuroblastoma
US10085979B2 · kind B2 · utility
7Cited by
4References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 30, 2015 |
| Grant date | Oct 2, 2018 |
| Priority date | — |
| Expiry date | Nov 30, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are methods of treating neuroblastoma in a cancer patient by administration of a Trk inhibitor in combination with one more chemotherapeutic agents. Also disclosed are pharmaceutical compositions comprising a Trk inhibitor and one or more chemotherapeutic agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.